These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 18050304
1. A new type of MAML2 fusion in mucoepidermoid carcinoma. Fehr A, Röser K, Heidorn K, Hallas C, Löning T, Bullerdiek J. Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304 [Abstract] [Full Text] [Related]
2. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma. Fehr A, Meyer A, Heidorn K, Röser K, Löning T, Bullerdiek J. Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953 [Abstract] [Full Text] [Related]
3. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma. Okumura Y, Miyabe S, Nakayama T, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H. Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476 [Abstract] [Full Text] [Related]
4. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Nakayama T, Miyabe S, Okabe M, Sakuma H, Ijichi K, Hasegawa Y, Nagatsuka H, Shimozato K, Inagaki H. Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740 [Abstract] [Full Text] [Related]
5. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma. Lennerz JK, Perry A, Dehner LP, Pfeifer JD, Lind AC. Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452 [Abstract] [Full Text] [Related]
11. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. Genes Chromosomes Cancer; 2007 Jul; 46(7):708-15. PubMed ID: 17437281 [Abstract] [Full Text] [Related]
12. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, Shimozato K, Eimoto T, Nakamura S, Nagai N, Hasegawa Y, Inagaki H. Clin Cancer Res; 2006 Jul 01; 12(13):3902-7. PubMed ID: 16818685 [Abstract] [Full Text] [Related]
17. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Chen Z, Chen J, Gu Y, Hu C, Li JL, Lin S, Shen H, Cao C, Gao R, Li J, Ha PK, Kaye FJ, Griffin JD, Wu L. Oncogene; 2014 Jul 17; 33(29):3869-77. PubMed ID: 23975434 [Abstract] [Full Text] [Related]
18. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland. Von Holstein SL, Fehr A, Heegaard S, Therkildsen MH, Stenman G. Oncol Rep; 2012 May 17; 27(5):1413-6. PubMed ID: 22323114 [Abstract] [Full Text] [Related]
20. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, Kirsch IR, Kaye FJ. Cancer Res; 2005 Aug 15; 65(16):7137-44. PubMed ID: 16103063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]